Filing Details
- Accession Number:
- 0000899243-22-038384
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-13 20:24:08
- Reporting Period:
- 2022-12-09
- Accepted Time:
- 2022-12-13 20:24:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750019 | Tcr2 Therapeutics Inc. | TCRR | Biological Products, (No Disgnostic Substances) (2836) | 474152751 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1875057 | Peter Olagunju | C/O Tcr2 Therapeutics 100 Binney Street Cambridge MA 02142 | Chief Technical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-09 | 1,561 | $1.13 | 27,361 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-12 | 1,610 | $1.10 | 25,751 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-12-13 | 1,659 | $1.07 | 24,092 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 28,922 | Direct |
Footnotes
- The sales reported represent the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and intended to qualify under Rule 10b5-1.
Billionaire Hedge Funds
